Nuvectis Pharma stock hits 52-week low at $4.7 amid market challenges By Investing.com
In a turbulent market environment, Nuvectis Pharma Inc. (NVCT) stock has reached a 52-week low, touching down at $4.7. This...
Read moreDetailsLatest Post
US Treasury targets Russia’s Gazprombank with new sanctions
By Timothy Gardner, Daphne Psaledakis WASHINGTON (Reuters) -The U.S. imposed fresh sanctions on Russia's Gazprombank on Thursday, the Treasury Department...
Read moreDetails
Central Asia Investing in Itself – The Diplomat
Uzbek President Shavkat Mirziyoyev’s visit to Astana in August 2024 marked the inaugural meeting of the Supreme Interstate Council of...
Read moreDetails
Green shipping corridors face a “feasibility wall”, says new report
The idea of green shipping corridors – referring to specific trade routes where the feasibility of zero-emission shipping is catalysed...
Read moreDetails
Children with coordination challenges may avoid physical activity. Here’s how to help them become active
Credit: Unsplash/CC0 Public Domain Children are born to play! And yet, despite our best efforts, many parents and professionals find...
Read moreDetails
